Hulthén L, Jonsson K, Lecerol H, Hökfelt B
Acta Endocrinol (Copenh). 1981 Feb;96(2):235-42.
Blood kinin concentration and plasma renin activity (PRA) were determined in the renal veins and in the inferior caval vein (ICV) below the level of the renal veins in 9 normal individuals (5 men and 4 women) and 7 patients with primary aldosteronism (3 men and 4 women). PRA in the renal veins and ICV was significantly lower and plasma aldosterone concentration in ICV significantly higher in the patients as compared to the normals. Kinin concentration in the renal veins and ICV did not differ significantly between the patients and the normals (0.31 +/- 0.04 (mean +/- SEM) vs 0.45 +/- 0.03 and 0.27 +/- 0.05 vs 0.45 +/- 0.06 microgram/l, respectively). In the normal individuals kinin concentration and PRA were inversely related in the left renal vein (r = -0.80; P less than 0.02), whereas this relation did not reach statistical significance in the right renal vein (r = -0.60; P less than 0.10). Kinin concentration in both renal veins was positively correlated to kinin concentration in ICV (r = 0.73; P less than 0.05 and r = 0.83; P less than 0.02 for the right and left renal vein, respectively). These results indicate that intrarenal kinin formation and renin release are inversely related in normal subjects. Furthermore, they suggest that one and the same enzyme, possibly renal kallikrein, may be implicated in the kinin formation in the systemic as well as in the renal circulation. Intrarenal kinin formation seems not to be increased in primary aldosteronism.
在9名正常个体(5名男性和4名女性)以及7名原发性醛固酮增多症患者(3名男性和4名女性)中,测定了肾静脉以及肾静脉水平以下的下腔静脉(ICV)中的血液激肽浓度和血浆肾素活性(PRA)。与正常个体相比,患者肾静脉和ICV中的PRA显著降低,ICV中的血浆醛固酮浓度显著升高。患者与正常个体肾静脉和ICV中的激肽浓度无显著差异(分别为0.31±0.04(均值±标准误)对0.45±0.03以及0.27±0.05对0.45±0.06微克/升)。在正常个体中,左肾静脉中的激肽浓度与PRA呈负相关(r = -0.80;P < 0.02),而右肾静脉中的这种关系未达到统计学显著性(r = -0.60;P < 0.10)。双侧肾静脉中的激肽浓度与ICV中的激肽浓度呈正相关(右肾静脉和左肾静脉的r分别为0.73;P < 0.05和r = 0.83;P < 0.02)。这些结果表明,在正常受试者中,肾内激肽形成与肾素释放呈负相关。此外,它们提示同一种酶,可能是肾激肽释放酶,可能参与全身循环以及肾循环中的激肽形成。原发性醛固酮增多症患者的肾内激肽形成似乎未增加。